INTERVIEW – ABC RADIO NATIONAL – RD DRIVE

Topics: COVID-19 vaccine rollout, repatriation from India, violent extremism PATRICIA KARVELAS: Karen Andrews is the Minister for Home Affairs and my guest this evening. Welcome to the program. KAREN ANDREWS: Hi Patricia. PATRICIA KARVELAS: Do you agree a new and better national advertising campaign is needed to combat vaccine hesitancy? KAREN ANDREWS: Look, we’re clearly…

TRANSCRIPT INTERVIEW – SKY NEWS – SUNDAY AGENDA

Topics: International borders, skilled migration, vaccine manufacturing, Sri Lankan family, aged care E&OE: ANDREW CLENNELL: Okay, so now I’m joined by the Home Affairs Minister Karen Andrews. Minister, thanks for joining us. KAREN ANDREWS: A pleasure. ANDREW CLENNELL: We’ve heard here from Greg Hunt, Scott Morrison, different versions of what might happen with the opening…

$41.7 million boost to commercialise lifesaving medical discoveries

An innovative nasal treatment to fight COVID-19, common colds and flu is being taken to the next stage of testing, thanks to the Morrison Government’s $500 million Biomedical Translation Fund. Developed by Australian biotech company Ena Respiratory, INNA-051 works by stimulating the innate immune system, the first line of defence against the invasion of pathogens…

$1 BILLION MANUFACTURING AGREEMENT SECURES AUSTRALIA’S NATIONAL HEALTH SECURITY

A new high-tech vaccine manufacturing facility will be developed in Melbourne to secure Australia’s long-term supply of critical health products including pandemic influenza vaccines and life-saving antivenoms. The $1 billion agreement between the Morrison Government and Seqirus also provides the ability to rapidly manufacture vaccines when responding to health pandemics in the future. Prime Minister…

TRANSCRIPT Interview – Sunrise

Topics: COVID-19 vaccine E&OE: Natalie Barr: Well the Government has struck two coronavirus vaccine deals. They’ll give Australia access to potential treatments from both the University of Queensland and Oxford University. Both vaccines are in advanced stages of testing. The agreements are worth $1.7 billion, and would secure around 85 million doses which would be…